Published in Biochemistry on October 03, 2006
Conformational changes in the expression domain of the Escherichia coli thiM riboswitch. Nucleic Acids Res (2007) 1.17
Liquid-crystal NMR structure of HIV TAR RNA bound to its SELEX RNA aptamer reveals the origins of the high stability of the complex. Proc Natl Acad Sci U S A (2008) 0.99
Quality control of bacterial mRNA decoding and decay. Biochim Biophys Acta (2008) 0.98
Stability and mismatch discrimination of locked nucleic acid-DNA duplexes. Biochemistry (2011) 0.94
Exploring TAR-RNA aptamer loop-loop interaction by X-ray crystallography, UV spectroscopy and surface plasmon resonance. Nucleic Acids Res (2008) 0.87
Efficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites. Retrovirology (2007) 0.87
The crystal structure of an 'All Locked' nucleic acid duplex. Nucleic Acids Res (2010) 0.87
A designed RNA selection: establishment of a stable complex between a target and selectant RNA via two coordinated interactions. Nucleic Acids Res (2009) 0.82
Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy. Curr Genomics (2015) 0.81
In vitro selection of BNA (LNA) aptamers. Artif DNA PNA XNA (2013) 0.81
A combinatorial approach to the repertoire of RNA kissing motifs; towards multiplex detection by switching hairpin aptamers. Nucleic Acids Res (2016) 0.77
Prostate-specific RNA aptamer: promising nucleic acid antibody-like cancer detection. Sci Rep (2015) 0.77
Inhibition of HIV Replication by Cyclic and Hairpin PNAs Targeting the HIV-1 TAR RNA Loop. J Nucleic Acids (2012) 0.77
An in vitro selection scheme for oligonucleotide probes to discriminate between closely related DNA sequences. Nucleic Acids Res (2007) 0.76
Aptamers against pathogenic microorganisms. Crit Rev Microbiol (2015) 0.75
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res (2007) 5.67
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci U S A (2009) 2.00
MicroRNAs in liver disease. Gastroenterology (2012) 1.76
Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSF. Nucleic Acids Res (2009) 1.72
A boost for the emerging field of RNA nanotechnology. ACS Nano (2011) 1.17
SPC3042: a proapoptotic survivin inhibitor. Mol Cancer Ther (2008) 1.15
A promoter activity is present in the DNA sequence corresponding to the hepatitis C virus 5' UTR. Nucleic Acids Res (2003) 1.11
HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens. J Antimicrob Chemother (2010) 1.08
Reconstitution of proapoptotic BAK function in liposomes reveals a dual role for mitochondrial lipids in the BAK-driven membrane permeabilization process. J Biol Chem (2011) 1.08
Monomeric nucleoprotein of influenza A virus. PLoS Pathog (2013) 1.07
Riboproteomic analysis of polypeptides interacting with the internal ribosome-entry site element of foot-and-mouth disease viral RNA. Proteomics (2008) 1.06
Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation. Nucleic Acids Res (2003) 1.06
Liquid-crystal NMR structure of HIV TAR RNA bound to its SELEX RNA aptamer reveals the origins of the high stability of the complex. Proc Natl Acad Sci U S A (2008) 0.99
LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1. Nucleic Acids Res (2004) 0.97
Molecular dynamics reveals the stabilizing role of loop closing residues in kissing interactions: comparison between TAR-TAR* and TAR-aptamer. Nucleic Acids Res (2003) 0.97
Apical loop-internal loop interactions: a new RNA-RNA recognition motif identified through in vitro selection against RNA hairpins of the hepatitis C virus mRNA. Biochemistry (2002) 0.97
Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus. Antimicrob Agents Chemother (2013) 0.96
Selective inhibitory DNA aptamers of the human RNase H1. Nucleic Acids Res (2003) 0.95
Aptamers: a new class of oligonucleotides in the drug discovery pipeline? Curr Opin Pharmacol (2009) 0.93
K65R in subtype C HIV-1 isolates from patients failing on a first-line regimen including d4T or AZT: comparison of Sanger and UDP sequencing data. PLoS One (2012) 0.91
Loop-loop interaction of HIV-1 TAR RNA with N3'-->P5' deoxyphosphoramidate aptamers inhibits in vitro Tat-mediated transcription. Proc Natl Acad Sci U S A (2002) 0.91
Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification pattern. Nucleic Acid Ther (2013) 0.91
2'-O-methyl-RNA hairpins generate loop-loop complexes and selectively inhibit HIV-1 Tat-mediated transcription. Biochemistry (2002) 0.90
Molecular dynamics studies of the nucleoprotein of influenza A virus: role of the protein flexibility in RNA binding. PLoS One (2012) 0.89
The application of locked nucleic acids in the treatment of cancer. IDrugs (2006) 0.89
Resistance mutations and CTL epitopes in archived HIV-1 DNA of patients on antiviral treatment: toward a new concept of vaccine. PLoS One (2013) 0.88
Exploring TAR-RNA aptamer loop-loop interaction by X-ray crystallography, UV spectroscopy and surface plasmon resonance. Nucleic Acids Res (2008) 0.87
Detection of low-frequency HIV type 1 reverse transcriptase drug resistance mutations by ultradeep sequencing in naive HIV type 1-infected individuals. AIDS Res Hum Retroviruses (2013) 0.87
Endogenous expression of an anti-TAR aptamer reduces HIV-1 replication. RNA Biol (2006) 0.87
Use of dynamic combinatorial chemistry for the identification of covalently appended residues that stabilize oligonucleotide complexes. Angew Chem Int Ed Engl (2004) 0.87
SELEX and dynamic combinatorial chemistry interplay for the selection of conjugated RNA aptamers. Org Biomol Chem (2006) 0.87
General strategy for ordered noncovalent protein assembly on well-defined nanoscaffolds. Biomacromolecules (2013) 0.86
Dynamic and rapid changes in viral quasispecies by UDPS in chronic hepatitis C patients receiving telaprevir-based therapy. Antivir Ther (2013) 0.86
NMR structure of a kissing complex formed between the TAR RNA element of HIV-1 and a LNA-modified aptamer. Nucleic Acids Res (2007) 0.86
Determinants of apical loop-internal loop RNA-RNA interactions involving the HCV IRES. Biochem Biophys Res Commun (2004) 0.85
Direct evidence for RNA-RNA interactions at the 3' end of the Hepatitis C virus genome using surface plasmon resonance. RNA (2013) 0.83
Nucleic acids targeted to drugs: SELEX against a quadruplex ligand. Biochimie (2011) 0.83
Hexitol nucleic acid-containing aptamers are efficient ligands of HIV-1 TAR RNA. Biochemistry (2005) 0.83
LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1. Blood Cells Mol Dis (2007) 0.83
Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity. Oligonucleotides (2007) 0.82
In vitro selection of RNA aptamers derived from a genomic human library against the TAR RNA element of HIV-1. Biochemistry (2009) 0.82
Systematic screening of LNA/2'-O-methyl chimeric derivatives of a TAR RNA aptamer. FEBS Lett (2007) 0.82
A functional selection of viral genetic elements in cultured cells to identify hepatitis C virus RNA translation inhibitors. Nucleic Acids Res (2008) 0.81
In vitro selection of DNA aptamers against the HIV-1 TAR RNA hairpin. Antisense Nucleic Acid Drug Dev (2002) 0.81
Variability and recombination of clinical human cytomegalovirus strains from transplantation recipients. J Clin Virol (2010) 0.81
Single-cycle kinetic analysis of ternary DNA complexes by surface plasmon resonance on a decaying surface. Biochimie (2012) 0.80
Bimodal loop-loop interactions increase the affinity of RNA aptamers for HIV-1 RNA structures. Biochemistry (2006) 0.80
Deciphering aromatic oligoamide foldamer-DNA interactions. Angew Chem Int Ed Engl (2011) 0.80
HAPIscreen, a method for high-throughput aptamer identification. J Nanobiotechnology (2011) 0.80
Survivin mRNA antagonists using locked nucleic acid, potential for molecular cancer therapy. Nucleosides Nucleotides Nucleic Acids (2007) 0.80
Regulating eukaryotic gene expression with aptamers. FEBS Lett (2004) 0.80
In vitro selection procedures for identifying DNA and RNA aptamers targeted to nucleic acids and proteins. Methods Mol Biol (2005) 0.79
Pol bootscanning analysis of HIV type 1 can exhibit unexpected recombinations. AIDS Res Hum Retroviruses (2009) 0.79
(99m)Tc-MAG3-aptamer for imaging human tumors associated with high level of matrix metalloprotease-9. Bioconjug Chem (2012) 0.79
Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study). Antivir Ther (2015) 0.78
Surface plasmon resonance investigation of RNA aptamer-RNA ligand interactions. Methods Mol Biol (2011) 0.78
Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy. J Antimicrob Chemother (2011) 0.78
Viremia copy-years as a predictive marker of all-cause mortality in HIV-1-infected patients initiating a protease inhibitor-containing antiretroviral treatment. J Acquir Immune Defic Syndr (2015) 0.78
The guanine-quadruplex aptamer 93del inhibits HIV-1 replication ex vivo by interfering with viral entry, reverse transcription and integration. Antivir Ther (2011) 0.78
Mutations of the SL2 dimerization sequence of the hepatitis C genome abrogate viral replication. Cell Mol Life Sci (2015) 0.78
Sensitive liposomes encoded with oligonucleotide amphiphiles: a biocompatible switch. Chem Commun (Camb) (2008) 0.77
Aptamers as imaging agents. Expert Opin Med Diagn (2010) 0.77
Anti-HIV activity of steric block oligonucleotides. Ann N Y Acad Sci (2006) 0.77
Simulated single-cycle kinetics improves the design of surface plasmon resonance assays. Talanta (2013) 0.77
Specific or nonspecific protein-polyphenol interactions? Discrimination in real time by surface plasmon resonance. Chembiochem (2009) 0.76
Regulating mRNA translation with a kiss. Nucleic Acids Symp Ser (Oxf) (2008) 0.76
Activation of GCN2 upon HIV-1 infection and inhibition of translation. Cell Mol Life Sci (2013) 0.76
Advances in binder identification and characterisation: the case of oligonucleotide aptamers. N Biotechnol (2011) 0.76
Binding of filamentous actin and winding into fibrillar aggregates by the polyphenolic C-glucosidic ellagitannin vescalagin. Angew Chem Int Ed Engl (2011) 0.76
Riboswitches based on kissing complexes for the detection of small ligands. Angew Chem Int Ed Engl (2014) 0.76
Synthesis and biological evaluation of LNA phosphoramidates. Nucleosides Nucleotides Nucleic Acids (2008) 0.76
Aptamers targeting RNA molecules. Methods Mol Biol (2009) 0.76
Structure-based design of novel naproxen derivatives targeting monomeric nucleoprotein of Influenza A virus. J Biomol Struct Dyn (2014) 0.75
Inhibition of pre-mRNA splicing by a synthetic Blom7α-interacting small RNA. PLoS One (2012) 0.75
An improved design of the kissing complex-based aptasensor for the detection of adenosine. Anal Bioanal Chem (2015) 0.75
Nucleic acid aptamers. Methods (2016) 0.75
Comparative studies of tricyclo-DNA- and LNA-containing oligonucleotides as inhibitors of HIV-1 gene expression. Nucleosides Nucleotides Nucleic Acids (2007) 0.75
Encapsidation of RNA-polyelectrolyte complexes with amphiphilic block copolymers: toward a new self-assembly route. J Am Chem Soc (2012) 0.75
Aptamer-mediated nanoparticle interactions: from oligonucleotide-protein complexes to SELEX screens. Methods Mol Biol (2015) 0.75
[Hommage to Professor Claude Hélène]. Bull Cancer (2003) 0.75